BRTX stock · CUBE stock

BRTX vs CUBE

BioRestorative Therapies Inc (BRTX) versus CubeSmart (CUBE) — a side-by-side from cached financials, not a winner call.

BioRestorative Therapies Inc (BRTX) is a biotechnology company listed on NASDAQ.

CubeSmart (CUBE) is a reit - industrial company listed on US.

Latest reported BRTX revenue for 2024-12-31 was $401.0K. Net income was -$9.0M. Revenue was up 175.0% from 2023-12-31 to 2024-12-31. BRTX currently screens at market cap $10.2M.

Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.

BRTX currently screens at market cap $10.2M. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.

Not investment advice. Open the BRTX and CUBE stock pages for the full models.

Not investment advice.

Popular Stock Comparisons